Products - Acute coronary syndromes | Topic | NICE

Showing 8 products

Date | Title

New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Percutaneous insertion of a catheter-based intravascular microaxial flow pump for cardiogenic shock
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
25 March 2026
Surgical insertion of a catheter-based intravascular microaxial flow pump for cardiogenic shock
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
25 March 2026
Semaglutide for preventing major cardiovascular events in people with cardiovascular disease and overweight or obesity [ID6441]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
14 May 2026
Pelacarsen for reducing the risk of cardiovascular events in people with established cardiovascular disease and high lipoprotein (a) [ID6559]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Bioprosthetic or native Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA)
Status:
Topic prioritisation
Programme:
Interventional procedures guidance
Expected publication date:
TBC
CaRi-Heart for predicting cardiac risk in adults with suspected coronary artery disease (CAD)
Status:
In development
Programme:
Health technology evaluation
Expected publication date:
TBC
Enlicitide decanoate for treating hyperlipidaemia in people at risk of an atherosclerotic cardiovascular disease event [ID6656]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Tirzepatide for reducing the risk of major adverse cardiovascular events in people with type 2 diabetes and cardiovascular disease [TSID12347]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC